APYX - NASDAQ
Apyx Medical Corporation
$3.79
-0.26%Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
At a Glance
Live Snapshotapyx
Net Receivables
Last Annual Value
16.78M
3-Year CAGR
-3%
5-Year CAGR
-1%
10-Year CAGR
19%
Apyx Medical Corporation Competitors Analysis of Net Receivables
| Company | Net Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Apyx Medical Corporation NASDAQ:APYX | 16.78M | 6.2% | -4.5% | 13.5% | |
 Pro-Dex, Inc. NASDAQ:PDEX | 17.49M | 20.7% | 2.6% | 19.4% | |
 Rapid Micro Biosystems, Inc. NASDAQ:RPID | 3.13M | -17.5% | -11.1% | N/A | |
 Vivani Medical, Inc. NASDAQ:VANI | 654.00K | N/A | N/A | 9.1% | |
 DocGo Inc. NASDAQ:DCGO | 92.89M | -29.2% | 3.5% | N/A | |
 Anika Therapeutics, Inc. NASDAQ:ANIK | 23.69M | -3.5% | -4.5% | -1.5% | |
 Solana Company NASDAQ:HSDT | 0.00 | N/A | N/A | N/A | |
 LENSAR, Inc. NASDAQ:LNSR | 6.38M | 13.8% | 5.0% | N/A | |
 Microbot Medical Inc. NASDAQ:MBOT | 241.00K | -45.5% | 6.7% | 32.0% | |
 Owlet, Inc. NYSE:OWLT | 22.90M | 17.9% | 16.9% | N/A | |
 AVITA Medical, Inc. NASDAQ:RCEL | 9.09M | 4.7% | 21.5% | 48.9% |
Apyx Medical Corporation Fair Value Envelope
Related Guides
Continue your APYX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.